Observational, Safety Study in Subjects Using Insulin Detemir for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes Mellitus.
Phase of Trial: Phase IV
Latest Information Update: 21 Feb 2016
At a glance
- Drugs Insulin detemir (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Novo Nordisk
- 10 Jun 2017 Biomarkers information updated
- 13 Oct 2009 Actual patient number changed from 3621 to 3593 as reported by ClinicalTrials.gov.
- 22 Jul 2008 New trial record.